Argent Biopharma signs exclusive royalty-bearing licence with NLC
Licence covers antiviral products worldwide excluding China; TolloHealth rights in the U.S. are preserved.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Argent BioPharma Ltd ASX:RGT